Existing drugs may limit damage caused by HIV
Yale researchers have identified four drugs that may help minimize the long-term health effects of HIV infection, they report June 23 in the Journal of Clinical Investigation.
Jun 23, 2020
0
1
Yale researchers have identified four drugs that may help minimize the long-term health effects of HIV infection, they report June 23 in the Journal of Clinical Investigation.
Jun 23, 2020
0
1
(HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long supported by President Donald Trump as a possible panacea for COVID-19.
Jun 22, 2020
0
2
Yale doctors have developed a technique to predict whether cancer patients receiving a common chemotherapy drug are likely to experience heart failure as a result.
Jun 19, 2020
0
6
The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for COVID-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system ...
Jun 1, 2020
0
20
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear.
May 29, 2020
0
29
A new study by investigators from Brigham and Women's Hospital examines changes in prescription patterns in the United States during the COVID-19 pandemic.
May 29, 2020
0
47
(HealthDay)—Many patients with heart failure might live years longer if they were on a combination of newer medications, a study suggests.
May 27, 2020
0
5
Although heart disease is the leading cause of death in women, and older adults are more likely to have heart and vascular disease than young people, randomized clinical trials testing medications to lower cholesterol have ...
May 22, 2020
0
5
Patients with heart failure have substantially shorter life expectancies than people without this condition. Approximately 6.5 million people in the U.S. and over 64 million people worldwide have heart failure, and about ...
May 21, 2020
0
45
The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
May 7, 2020
0
1